US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist

479.100
-1.250-0.26%

Close Feb 26 16:00 ET

477.000
-2.100-0.44%

Pre 07:26 ET

123.03BMarket Cap-230.34P/E (TTM)

Vertex Pharmaceuticals Stock Forum

Teddy123

Jan 31 01:16

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

$Vertex Pharmaceuticals (VRTX.US)$
Revolutionary Gene Therapy CASGEVY Now Available Through NHS England: Major Win for Sickle Cell Patients

Teddy123

Jan 30 23:42

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

$Vertex Pharmaceuticals (VRTX.US)$
FDA Approves First Non-Opioid Pain Drug in 20 Years: Vertex's Game-Changing Alternative to Opioids

Stock_Drift

Jan 30 19:13

$Vertex Pharmaceuticals (VRTX.US)$

Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller

Lnova

Jan 28 03:25

$Vertex Pharmaceuticals (VRTX.US)$ am watching this one to see the outcome biopharmcatalys...
has options
“Suzetrigine: The FDA has assigned a PDUFA target action date of January 30, 2025, for suzetrigine for the treatment of moderate-to-severe acute pain. Suzetrigine was granted Priority Review by the FDA.
The Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act became effective on January 1st, 2025. The NOPAIN Act mandates that Medicare provide a separate add-on payment in the hospital outp...

101721316

Dec 29, 2024 04:21

$Vertex Pharmaceuticals (VRTX.US)$ long term play

Lnova

Dec 19, 2024 18:23

$Vertex Pharmaceuticals (VRTX.US)$
nfa

Vertex Stock Plunges 13% Over Pain Drug's Disappointing Study Results

Lnova

Dec 19, 2024 18:19

“SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain.
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...

SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain

Kevin Travers

Nov 15, 2024 15:20

Columns Market Falls to End All-Time High Week | Wall Street Today

In the end, a week that starts with an all-time high for the S&P 500, Dow Jones, and Nasdaq 100, ended with equities lower.
At 4:02 p.m. ET, the three indices closed lower. The $Dow Jones Industrial Average (.DJI.US)$ was off 0.70%, losing 300 points. The $S&P 500 Index (.SPX.US)$ was down 1.32% and the $Nasdaq Composite Index (.IXIC.US)$ was off 2.24%.
MACRO
In macro, core retail sales grew by 0.1% month over month, lower than estimated. ...

Live Stock Financial Podcast. What are you watching on the market?

Kevin Travers

Nov 15, 2024 10:12

Columns Market Falls Friday on Earnings | Live Stock

You will not get through the trading day without the news and animal spirits guiding the market. It is finally Friday, November 15th.
My name is Kevin Travers and the market is falling today- here is why.
$Alibaba (BABA.US)$ shares declined after a report from the firm Friday morning that it was facing a consumer demand slump, even though its AI cloud business grew 7% to $4.2B in its second fiscal quarter.
$Applied Materials (AMAT.US)$ fell 8% after r...